Agenda

NASP Meeting Agenda

The 7th NASP Annual Meeting & Expo​ will provide comprehensive information regarding all aspects of specialty pharmacy, including the evolution of the market, impact of specialty pharmacy on patients, and national legislative and regulatory policy. The meeting will also include a Specialty Pharmacy Law Conference offering CE and CLE credits to attendees; a one-day CSP Prep Course for pharmacists studying for October examinations given by the Specialty Pharmacy Certification Board for Certified Specialty Pharmacist certification; and a Home Infusion Post-Conference Workshop given by subject matter experts from the National Home Infusion Association (NHIA) offering CE credits to attendees.

More Information Coming Soon

NASP 2019 Schedule

Download PDF
Monday September 09, 2019
Time
Track
Session/Events
Faculty
Room Moderator
Meeting Room
02:00 PM - 04:00 PM
Day 1 Annual Meeting Educational Conference Sessions
Clinical C1
2019 State of Care: Cystic Fibrosis

Learning Objectives:

  • Highlight current standards of care within this disease area
  • Review new agents that had been approved since July 2018
  • Emphasize clinical pearls/best practice for managing patients clinically within the disease process

Operational O6
Reimbursement 2019

Learning Objectives:

  • Current update asto role of copay accumulator in patient benefit management
  • Look at best practices in relation to utilization of third-party financial support, including Foudnation Programs, co-pay cards, and Patient Assitance Programs
  • Discuss cost control and management, from patient through payor

Regulatory R3
Increased Oversight: Reviewing the Blueprint to Lower Drug Prices & 340B Proposed Updates

Learning Objectives:

  • Review the proposed plan from the federal government to provide foundational understanding 
  • Discuss changes that have occurred since plan wasinitially presented
  • Focus on proposed impact as it relates to the specialty pharmacy industry 

Clinical C2
2019 State of Care: Hepatology (HEPC, NASH)

Learning Objectives

  • Highlight current standards of care within this disease area
  • Review new agents that had been approved since July 2018
  • Emphasize clincal pearls / best practice for managing patients clinically within the disease process

Operational O5
Improving Data Standards for Specialty Pharmacy - A Multi-Stakeholder Panel (HUB, Aggregator, NCPDP, SP, Pharma partners)

Learning Objectives:

  • Open discussion surroudning key data elements shared across the specialty pharmacy industry
  • Provide insight as to elements of standardization attempted by key parties involved
  • Address challenges to further standardization of data, and highlight ways to overcome

Experience E2
Payor-SP Relationships: Building Synergies and True Partnerships (Panel)

Leanring Objective

  • Focus on best cast relationships between specialty pharmacies and payors, including clinical programs
  • Highlight approaches to specialty pharmacy contracting, key takeaways for capabilities, and cost management 
  • Review formulary management tactics from high-performing relationships and ways to implement industry wide 

04:00 PM - 05:00 PM
CE Satellite Symposium

 

05:30 PM - 07:30 PM
Welcome Reception and Networking

 

Tuesday September 10, 2019
Time
Track
Session/Events
Faculty
Room Moderator
Meeting Room
06:00 AM - 07:00 AM
Wellness Initiative (limited space, on-site sign up required)

 

07:00 AM - 08:00 AM
CE Satellite Symposium (breakfast provided)

 

07:00 AM - 08:00 AM
Breakfast

 

Exhibit Hall
08:00 AM - 12:00 PM
Day 2 Annual Meeting Educational Conference Sessions

 

Clinical C1
2019 State of Care: Cystic Fibrosis

Learning Objectives:

  • Highlight current standards of care within this disease area
  • Review new agents that had been approve since July 2018
  • Emphasizeclinical pearls / best practice for managing patientsclinically within the disease process

Regulatory R1
NASP in Action

Learning Objectives:

  • Deep dive of position papers & actionable specialty pharmacy advocacy initiated by NASP over last 12 months
  • Review of Cost of Dispense Results compiled by NASP
  • Highlight SPC Board partnership / current state of CSP Exam & industry acceptance

Experience E1
Innovation in Specialty: Pharmacogenomics, Artificial Intelligence, and Beyond

Learning Objectives:

  • Highlight key pharmacogenomics trends and case examples of its use in speciatly pharmacy practice
  • What does the future hold for specialty pharmacy and artificial intelligence?
  • Technology and specialty pharmacy seem like a perfect fit - how can that model adapt to benefit all stakeholders

Clinical C2
2019 State of Care: Hepatology (HEPC, NASH)

Learning Objectives:

  • Highlight current standards of care within this disease area
  • Review new agents that had been approved since July 2018
  • Emphasize clinical pearls / best practice formanaging patientsclinically within the disease process

Operational O2
Intake: Building Positive Relationships with Prescribers During Patient Onboarding

Learning Objectives:

  • Discuss referral management process and steps to receipt of referral
  • Highlight points of confusion related to intake period, and how to surmount challenges
    • Provide best practices in SP-prescriber relationships to improve conversations related to decreasing time-to-fill

Regulatory R2
Managing Regulations

Learning Objectives:

  • Review regulations affecting pharmacy operations, including prescription drug management programs,non-resident licensure, and accreditation
  • Identify key characteristics to gain efficiency in compliance with each
    • Discuss best practices demonstrate compliance with each aspect

Clinical C3
2019 State of Care: Inflammatory Diseases (RA, Psoriatic Arthritis, AS)

Learning Objectives:

  • Highlight current standards of care within this disease area
  • Review new agents that had been approved since July 2018
    • Emphasize clinical pearls / best practice for managing patients clinically within the disease process

Operational O3
Fulfillment: Aligning Processes to Best Standards of Care

Learning Objectives:

  • Review updates to prescription handling and cold chain management standards
  • Establish best practices to compy by Drug Supply Chain Security Act (DSCSA)
    • Identify advancements in packaging, returns handling, and all areas of fulfillment expertise 

Experience E3
Outcomes / Value Based Care

Learning Objectives:

  • Review public case examples of value-based care in action
  • Takeaway key learnings from specialty pharmacy involvement in outcomes management and true value-based care
    • Identify key areas for specialty pharmacy growth to aid in this area

Clinical C4
2019 State of Care: Multiple Sclerosis

Learning Objectives:

  • Highlight current standards of care within this disease area
  • Review new agents that had been approved since July 2018
    • Emphasize clinical pearls / best practice for managing pateints clinically within the disease process

Regulatory R4
Biosimilar Action Plan

Learning Objectives:

  • Provide an overview of the FDA's Biosimilar Action Plan
  • Discuss status of plan and changes that have occurred sinceinitial presentation
    • Review current state of biosimilar medications and the Action PLan's proposed impact on growth oft hsi industyr segment

Experience E4
Health System Pharmacy: Enhancing Transitions Across Multiple Sites of Care

Learning Objectives:

  • Evaluate the landscape of health system specialty pharmacy growth
  • Propose models of efficiency related to health system, integrated delivery, or hybrid models of care
    • Highlight practice pearls for managing transition of care from diagnosis through outpatient journey as well as foundational inquiries about beginning the process of building a SP

12:00 PM - 01:00 PM
CE Satellite Symposium (lunch provided)

Adolescent Atopic Dermatitis

12:00 PM - 01:00 PM
Lunch Break (lunch provided in Exhibit Hall)

 

01:00 PM - 02:00 PM
Networking

 

02:00 PM - 05:30 PM
Day 2 Annual Meeting Educational Conference Sessions

 

Clinical C5
2019 State of Care: Oncology / Hematology

Learning Objectives:

  • Highlight current standards of care withint this disease state
  • Review new agents that had been approved since July 2018
  • Emphsize clinical pearls / best practice for managing patients clinically within the disease process

Operational O5
Improving Data Standards for Specialty Pharmacy - A Multi-Stakeholder Panel (HUB, Aggregator, NCPDP, SP, Pharma partners)

Learning Objectives:

  • Open discussion surrounding key data elements shared across the specialty pharmacy industry
  • Provide insight as to elements of standardization attempted by key parties involved
    • Address challenges to further standardization of data and highlight ways to overcome

Regulatory R5
Partnering with NASP

Learning Objectives:

  • Highlight SPC Board partnership / current state of CSP Exam & industry acceptance
  • Overview of SP Satisfaction Survey results focused on multiple stakeholder perspectives
    • Detail sales training & CE initiatives forthcoming from NASP

Clinical C6
2019 Pipeline Review (Capture agents not included in categories above)

Learning Objectives:

  • Highlight current standards of care within this disease area
  • Review new agents that had been approved since July 2018
    • Emphasize clinical pearls / best practice for managing patients clinically within the disease process

Operational O6
Reimbursement 2019

Learning Objectives:

  • Current update as to role of copay accumulator in patient beneift management 
  • Look at best practices in relation to utilization of third-party financial support, including Foundation Programs, co-pay cards, and Patient Assistance Programs
    • Discuss cost control and management, from patient through payor

Experience E6
Manufacturer - SP Relationships: A Model for Commercial Success

Learning Objectives:

  • Focus on best case relationships between specialty pharmacies and manufacturers, including clinical programs
  • Highlight approaches to speciatly pharmacy contracting,  key takeaways for capabilities and cost management 
    • Review case examples of high-performing limited distribution models and the pros/cons across the supply chain

05:30 PM - 06:30 PM
CE Satellite Symposium

 

06:30 PM - 07:30 PM
Poster Presentations and Author Discussions

 

Exhibit Hall
06:30 PM - 08:00 PM
Meet the Board / Member Appreciation Reception

 

Wednesday September 11, 2019
Time
Track
Session/Events
Faculty
Room Moderator
Meeting Room
06:00 AM - 07:00 AM
Wellness Initiative (limited space, on-site sign up required)

 

07:00 AM - 08:00 AM
CE Satellite Symposium (breakfast provided)

 

07:00 AM - 08:00 AM
Breakfast

 

Exhibit Hall
08:00 AM - 12:00 PM
Day 3 Annual Meeting Educational Conference Sessions

 

Product Pipeline Update

 

NASP - Year in Review

 

Clinical C3
2019 State of Care: Inflammatory Diseases (RA, Psoriatic Arthritis, AS)

Learning Objectives:

  • Highlight current standards of care within this disease state
  • Review new agents that had been approved since July 2018
    • Emphasize clinical pearls / best practice for managing patients clinically within the disease process

Experience E7
Rare Disease Panel

Learning Objectives:

  • Review multistakeholder considerations for rare disease therapy management, including accreditors, specialty pharmacy, payors, and geneticists
  • Determine the impact of rare disease therapies via case studies on each of the associated stakeholders
    • Discuss best practices needed for handling and management of rare disease therapies within the specialty pharmacy continuum

Experience E1
Innovation in Specialty: Pharmacogenomics, Artificial Intelligence, and Beyond

Learning Objectives:

  • Highlight key pharmacogenomics trends and case examples of its use in specialty pharmacy practice
  • What does the future hold for specialty pharmacy and artificial intelligence?
    • Technology and specialty pharmacy seem like a perfect fit - how can that model adapt to benefit all stakeholders

Clinical C4
2019 State of Care: Multiple Sclerosis

Learning Objectives:

  • Highlight current standards of care within this disease area
  • Review new agents that had been approved since July 2018
    • Emphasize clinical pearls / best practice for managing patients clinically within the disease process

Operational O4
Streamlining the Specialty Prescribing Process: How Technology Can Accelerate Time to Therapy

Learning Objectives:

  • Define the role technology plays in speed to therapy
  • Identify the challenges in specialty prescribing
    • Articulate the outcomes seen from utilization of technology solutions in specialty prescribing

Regulatory R6
DIR Fees

Learning Objectives:

  • Review current state of DIR on teh specialty pharmacy industry
  • Identify changes that have occurred related to legislation and management over the last several months
    • Discuss best practicesfor handling, management of, and advocacy related to the future of DIR

11:30 AM - 01:00 PM
Women in Specialty Pharmacy Luncheon (requires separate registration)

Allison Massari

12:00 PM - 01:00 PM
CE Satellite Symposium (lunch provided)

 

12:00 PM - 01:00 PM
Lunch Break (lunch provided in Exhibit Hall)

 

01:00 PM - 02:00 PM
Networking

 

02:00 PM - 04:00 PM
Day 3 Annual Meeting Educational Conference Sessions

 

Clinical C5
2019 State of Care: Oncology / Hematology

Learning Objectives:

  • Highlight current standards of care within this disease area
  • Review new agents that had been approved since July 2018
    • Emphasize clincal pearls / best practice for managing patients clinically within the disease process

Operational O1
Beyond MPR / PDC: Ways to Promote and Measure Adherence with Your Patients

Learning Objectives:

  • Review Medication Possession Ratio and Proportion of Days Covered as indicator of patient adherence / non-adherence
  • Discuss other markers for patient adherence
    • Case study of best practices related to driving patient adherence through intervention and engagement

Experience E3
Outcomes / Value Based Care

Learning Objectives:

  • Review public case examples of value-based care in action
  • Take away key learnings from specialty pharmacy involvement in outcomes mangement and true value-based care
    • Identify key areas for specialty pharmcy growth to aid in this area

Clinical C6
2019 Pipeline Review (Capture agents not included in categories above)

Learning Objectives:

  • Highlight current standards of care within this disease area
  • REview new agents that had been approved since July 2018
    • Emphasize clinical pearls / best practice for managing patients clinically within the disease process

Regulatory R2
Managing Regulations

Learning Objectives:

  • Review regulations affecting pharmacy operations, including prescription drug management programs, non-resident licensure, and accreditation
  • Identify key characteristics to gain efficiency in compliance with each
    • Discuss best practices demonstrate complianace with each aspect

Experience E5
Enhanced Services & the Patient Journey - Coordinating Care to Ensure Patient Success

Learning Objectives:

  • Distinguish between core and enhanced specialty pharmacy offerings
  • Compare different service models, including internal or external HUB service providers
    • Illustrate successful enhanced service programs and the value afforded to the patient journey, including staffing models with nursing

04:00 PM - 05:00 PM
Annual Meeting Adjournment

 

06:00 PM - 08:00 PM
Activity / Tour

 

Thursday September 12, 2019
Time
Track
Session/Events
Faculty
Room Moderator
Meeting Room
07:00 AM - 08:00 AM
Post-Conference Workshops Registration and Breakfast

 

08:00 AM - 05:30 PM
NASP 4th Annual Specialty Pharmacy Law Conference - Legal Day (requires separate registration and fee)

 

08:00 AM - 05:00 PM
Home Infusion Workshop (requires separate registration and fee)

 

08:00 AM - 05:00 PM
CSP Exam Prep Course (requires separate registration and fee)

 

 
*Final agenda will be posted in September 2019